ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BFNM3G45
Stock Name / FundiShares MSCI USA ESG Screened UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerSASU(USD) LSE
ETF TickerGPSA(GBP) LSE
ETF TickerSGAS(EUR) F
ETF TickerGPSA.LS(GBP) CXE
ETF TickerSASU.LS(USD) CXE
ETF TickerSASUz(USD) CXE
ETF TickerSGAS.DE(EUR) CXE
ETF TickerSASU.L(GBP) LSE
ETF TickerGPSA.L(GBP) LSE

Holdings detail for ALNY

Stock NameAlnylam Pharmaceuticals Inc
TickerALNY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS02043Q1076
LEI529900S3ZI14OWRJII50

Show aggregate ALNY holdings

News associated with ALNY

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $500.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price increased by Royal Bank Of Canada from $435.00 to $500.00 in a report issued on Friday morning,Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. ALNY has been the topic of several other reports. The Goldman Sachs Group boosted their price […] - 2025-09-22 02:32:43
Alnylam Pharmaceuticals (NASDAQ:ALNY) Given New $520.00 Price Target at Bank of America
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective raised by Bank of America from $453.00 to $520.00 in a research report report published on Wednesday,Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. A number of other equities analysts have also weighed in on ALNY. Oppenheimer upgraded shares […] - 2025-09-18 04:26:54
The Goldman Sachs Group Forecasts Strong Price Appreciation for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price increased by The Goldman Sachs Group from $504.00 to $566.00 in a report published on Tuesday,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also commented on the stock. Chardan Capital lifted […] - 2025-09-17 03:14:44
Brokerages Set Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) PT at $421.28
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty-seven analysts that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and twenty-three have issued a buy recommendation on the company. The average 1 year target price […] - 2025-09-15 02:47:58
Alnylam Announces Pricing Of Upsized Offering Of $575 Mln Convertible Senior Notes Due 2028
(RTTNews) - Alnylam Pharmaceuticals Inc. (ALNY) announced the pricing of its private offering of $575 million aggregate principal amount of 0.00% convertible senior notes due 2028. The size of the offering was increased from the previously announced offering of $500 million aggre - 2025-09-10 00:33:28
Alnylam Pharma Commences Private Offering Of $500 Mln Of Convertible Senior Notes Due 2028
(RTTNews) - Alnylam Pharmaceuticals Inc. (ALNY) announced that it has commenced a private offering of $500 million aggregate principal amount of convertible senior notes due 2028. In connection with this offering, Alnylam expects to grant the initial purchasers of the notes an op - 2025-09-09 00:30:30
ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win
Alnylam and Roche report positive phase II KARDIA-3 results for zilebesiran in high-risk hypertension patients, fueling momentum for a phase III study. - 2025-09-01 11:50:00
Notable ETF Outflow Detected - XBI, ALNY, HALO, INSM
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $119.6 million dollar outflow -- that's a 2.2% decrease week over week - 2025-08-28 11:56:11
Dennis A. Ausiello Sells 31,448 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Stock
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) Director Dennis A. Ausiello sold 31,448 shares of the company’s stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $436.58, for a total value of $13,729,567.84. Following the completion of the sale, the director directly owned 911 shares in […] - 2025-08-18 05:14:55
LPL Financial LLC Buys 2,107 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
LPL Financial LLC grew its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 11.3% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 20,679 shares of the biopharmaceutical company’s stock after acquiring an additional 2,107 shares during the period. LPL Financial LLC’s holdings […] - 2025-08-13 05:04:56
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Cetera Investment Advisers Has $2.17 Million Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Cetera Investment Advisers raised its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 68.1% during the first quarter, Holdings Channel reports. The firm owned 8,017 shares of the biopharmaceutical company’s stock after purchasing an additional 3,247 shares during the period. Cetera Investment Advisers’ holdings in Alnylam Pharmaceuticals were worth $2,165,000 at the end […] - 2025-08-08 04:44:59
Alnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded at Oppenheimer
Oppenheimer upgraded shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) from a market perform rating to an outperform rating in a research report sent to investors on Monday, Marketbeat.com reports. The brokerage currently has $490.00 target price on the biopharmaceutical company’s stock. ALNY has been the subject of several other reports. Barclays lifted their price […] - 2025-08-07 02:54:47
Alnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded by Wolfe Research to Peer Perform Rating
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was upgraded by equities research analysts at Wolfe Research from an “underperform” rating to a “peer perform” rating in a research report issued on Monday, Marketbeat reports. A number of other brokerages have also recently issued reports on ALNY. Canaccord Genuity Group lifted their price target on shares […] - 2025-08-06 03:02:54
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $400.00 at Chardan Capital
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective lifted by Chardan Capital from $325.00 to $400.00 in a research report report published on Friday,Benzinga reports. Chardan Capital currently has a buy rating on the biopharmaceutical company’s stock. Several other research analysts have also issued reports on ALNY. Needham & Company LLC raised their […] - 2025-08-04 02:48:47
Needham & Company LLC Raises Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $478.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target hoisted by Needham & Company LLC from $377.00 to $478.00 in a research report report published on Thursday morning,Benzinga reports. Needham & Company LLC currently has a buy rating on the biopharmaceutical company’s stock. A number of other research analysts also recently commented on the […] - 2025-08-03 05:28:56
Noteworthy ETF Outflows: XBI, MRNA, ALNY, EXEL
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $225.3 million dollar outflow -- that's a 4.6% decrease week over week - 2025-07-30 11:49:03
Y Intercept Hong Kong Ltd Has $1 Million Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Y Intercept Hong Kong Ltd lessened its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 17.6% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,720 shares of the biopharmaceutical company’s stock after selling 796 shares during the period. […] - 2025-07-25 06:12:53
Victory Capital Management Inc. Cuts Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Victory Capital Management Inc. lowered its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 5.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,649 shares of the biopharmaceutical company’s stock after selling 2,148 shares during the period. Victory Capital […] - 2025-07-25 05:14:50
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Recommendation of “Moderate Buy” from Brokerages
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-six research firms that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and twenty-two have assigned a buy recommendation to the […] - 2025-07-24 06:26:55
Alnylam Pharmaceuticals (NASDAQ:ALNY) Now Covered by Truist Financial
Truist Financial initiated coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report sent to investors on Monday, Marketbeat reports. The firm issued a buy rating and a $385.00 price target on the biopharmaceutical company’s stock. A number of other equities research analysts also recently issued reports on ALNY. Jefferies Financial […] - 2025-07-22 03:14:59
Nisa Investment Advisors LLC Cuts Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Nisa Investment Advisors LLC cut its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 38.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,155 shares of the biopharmaceutical company’s stock after selling 5,162 shares during […] - 2025-07-14 05:54:56
Crossmark Global Holdings Inc. Takes Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Crossmark Global Holdings Inc. purchased a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 1,018 shares of the biopharmaceutical company’s stock, valued at approximately $275,000. Other hedge funds have also modified their holdings of the […] - 2025-07-14 05:14:48
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. decreased its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 6.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,691 shares of the biopharmaceutical company’s stock after selling 113 shares during the […] - 2025-07-08 04:40:51
Mirae Asset Global Investments Co. Ltd. Sells 2,596 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Mirae Asset Global Investments Co. Ltd. reduced its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 28.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,534 shares of the biopharmaceutical company’s stock after selling 2,596 shares during the […] - 2025-07-04 04:52:27
Wells Fargo & Company Raises Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $333.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its price target lifted by research analysts at Wells Fargo & Company from $287.00 to $333.00 in a report released on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the biopharmaceutical company’s stock. Wells Fargo & Company‘s price objective would suggest a potential upside […] - 2025-07-02 03:05:01
Diversified Trust Co Sells 999 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Diversified Trust Co cut its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 40.3% in the first quarter, Holdings Channel reports. The institutional investor owned 1,482 shares of the biopharmaceutical company’s stock after selling 999 shares during the period. Diversified Trust Co’s holdings in Alnylam Pharmaceuticals were worth $400,000 as of […] - 2025-07-01 07:10:56
Sequoia Financial Advisors LLC Boosts Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Sequoia Financial Advisors LLC lifted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 3.0% in the first quarter, HoldingsChannel reports. The fund owned 3,395 shares of the biopharmaceutical company’s stock after acquiring an additional 99 shares during the period. Sequoia Financial Advisors LLC’s holdings in Alnylam Pharmaceuticals were worth $917,000 […] - 2025-07-01 05:22:50
Alnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 12-Month High Following Analyst Upgrade
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) hit a new 52-week high on Monday after Wells Fargo & Company raised their price target on the stock from $287.00 to $333.00. Wells Fargo & Company currently has an equal weight rating on the stock. Alnylam Pharmaceuticals traded as high as $327.05 and last […] - 2025-07-01 02:27:01
Kentucky Retirement Systems Buys New Shares in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Kentucky Retirement Systems bought a new stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 8,794 shares of the biopharmaceutical company’s stock, valued at approximately $2,375,000. Several other institutional investors and […] - 2025-06-24 06:20:52

iShares MSCI USA ESG Screened UCITS ETF USD (Acc) ALNY holdings

DateNumber of ALNY Shares HeldBase Market Value of ALNY SharesLocal Market Value of ALNY SharesChange in ALNY Shares HeldChange in ALNY Base ValueCurrent Price per ALNY Share HeldPrevious Price per ALNY Share Held
2026-02-09 (Monday)43,287USD 13,851,840USD 13,851,840
2026-02-06 (Friday)43,335USD 14,220,814USD 14,220,814
2026-01-30 (Friday)43,231ALNY holding increased by 56USD 14,614,672ALNY holding decreased by -357986USD 14,614,67256USD -357,986 USD 338.06 USD 346.79
2026-01-29 (Thursday)43,175ALNY holding increased by 16USD 14,972,658ALNY holding decreased by -114865USD 14,972,65816USD -114,865 USD 346.79 USD 349.58
2026-01-28 (Wednesday)43,159USD 15,087,523ALNY holding decreased by -223132USD 15,087,5230USD -223,132 USD 349.58 USD 354.75
2026-01-27 (Tuesday)43,159ALNY holding increased by 264USD 15,310,655ALNY holding decreased by -189453USD 15,310,655264USD -189,453 USD 354.75 USD 361.35
2026-01-26 (Monday)42,895ALNY holding increased by 56USD 15,500,108ALNY holding increased by 164603USD 15,500,10856USD 164,603 USD 361.35 USD 357.98
2026-01-23 (Friday)42,839ALNY holding decreased by -48USD 15,335,505ALNY holding decreased by -532685USD 15,335,505-48USD -532,685 USD 357.98 USD 370
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ALNY by Blackrock for IE00BFNM3G45

Show aggregate share trades of ALNY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-01-30BUY56346.010336.390 337.352USD 18,892 -
2026-01-29BUY16350.340345.010 345.543USD 5,529 -
2026-01-27BUY264368.070354.690 356.028USD 93,991 -
2026-01-26BUY56364.070352.500 353.657USD 19,805 -
2026-01-23SELL-48371.330356.790 358.244USD -17,196 -
2026-01-22BUY32376.870363.360 364.711USD 11,671 -
2026-01-20SELL-48355.740347.860 348.648USD -16,735 -
2026-01-16SELL-24367.200355.460 356.634USD -8,559 -
2026-01-15BUY24372.820356.840 358.438USD 8,603 -
2026-01-14SELL-200371.600359.950 361.115USD -72,223 -
2026-01-09SELL-176409.480392.560 394.252USD -69,388 -
2026-01-08BUY80425.190393.480 396.651USD 31,732 -
2026-01-05SELL-432400.000383.840 385.456USD -166,517 -
2026-01-02BUY48407.220396.090 397.203USD 19,066 -
2025-12-29BUY32402.720397.050 397.617USD 12,724 -
2025-12-23BUY152407.425396.020 397.160USD 60,368 -
2025-12-22BUY112413.490403.200 404.229USD 45,274 -
2025-12-18SELL-144404.190391.510 392.778USD -56,560 -
2025-12-17BUY144400.210389.000 390.121USD 56,177 -
2025-12-16BUY152399.570388.540 389.643USD 59,226 -
2025-12-12BUY176410.040387.030 389.331USD 68,522 -
2025-12-11BUY24414.220402.220 403.420USD 9,682 -
2025-12-10BUY88416.970403.805 405.121USD 35,651 -
2025-12-05SELL-8473.500455.320 457.138USD -3,657 -
2025-12-04SELL-80476.810463.030 464.408USD -37,153 -
2025-12-03BUY48479.790460.460 462.393USD 22,195 -
2025-12-02BUY704472.480453.330 455.245USD 320,492 -
2025-11-28BUY80455.755444.430 445.562USD 35,645 -
2025-11-26SELL-24447.690430.270 432.012USD -10,368 -
2025-11-26SELL-24447.690430.270 432.012USD -10,368 -
2025-11-25BUY136441.820428.570 429.895USD 58,466 -
2025-11-24BUY296444.670420.345 422.778USD 125,142 -
2025-11-20BUY8467.730445.340 447.579USD 3,581 -
2025-11-19BUY48465.320456.900 457.742USD 21,972 -
2025-11-18BUY144469.110456.270 457.554USD 65,888 -
2025-11-17BUY64463.750449.000 450.475USD 28,830 -
2025-11-14SELL-48461.960448.280 449.648USD -21,583 -
2025-11-12BUY288459.270447.130 448.344USD 129,123 -
2025-11-10BUY160449.680440.930 441.805USD 70,689 -
2025-11-07SELL-16443.587430.835 432.110USD -6,914 -
2025-11-06SELL-32445.490429.000 430.649USD -13,781 -
2025-11-05BUY104438.530417.000 419.153USD 43,592 -
2025-11-04BUY128431.500421.830 422.797USD 54,118 -
2025-11-03SELL-64457.260429.615 432.379USD -27,672 -
2025-10-30BUY400471.980436.512 440.059USD 176,023 -
2025-10-29BUY400481.590482.730 482.616USD 193,046 -
2025-10-28BUY40475.910484.610 483.740USD 19,350 -
2025-10-27BUY24478.580485.360 484.682USD 11,632 -
2025-10-24BUY16463.430469.290 468.704USD 7,499 -
2025-10-21BUY24474.000490.050 488.445USD 11,723 -
2025-10-20BUY88491.220495.550 495.117USD 43,570 -
2025-10-16BUY80481.070488.390 487.658USD 39,013 -
2025-10-15BUY96470.270485.280 483.779USD 46,443 -
2025-10-06BUY72452.000458.690 458.021USD 32,978 -
2025-10-03BUY32456.350465.010 464.144USD 14,853 -
2025-10-02BUY64460.990461.530 461.476USD 29,534 -
2025-10-01BUY96460.650467.420 466.743USD 44,807 -
2025-09-30BUY584456.000459.300 458.970USD 268,038 -
2025-09-29BUY152447.490451.630 451.216USD 68,585 -
2025-09-26BUY344446.400453.050 452.385USD 155,620 -
2025-09-25BUY24449.580459.000 458.058USD 10,993 -
2025-09-18BUY96452.170456.940 456.463USD 43,820 -
2025-09-17BUY120451.730463.880 462.665USD 55,520 -
2025-09-16BUY192461.240467.280 466.676USD 89,602 -
2025-09-15BUY64461.140466.240 465.730USD 29,807 -
2025-09-11SELL-8468.580474.340 473.764USD -3,790 -
2025-08-15BUY16448.910449.520 449.459USD 7,191 -
2025-08-13BUY8432.520438.230 437.659USD 3,501 -
2025-07-31BUY40392.240402.430 401.411USD 16,056 -
2025-07-29BUY160330.550331.060 331.009USD 52,961 -
2025-07-28BUY32324.790331.430 330.766USD 10,585 -
2025-07-25BUY48328.810331.500 331.231USD 15,899 -
2025-07-24BUY24328.000332.190 331.771USD 7,963 -
2025-07-23BUY56325.640329.340 328.970USD 18,422 -
2025-07-22BUY32325.280326.300 326.198USD 10,438 -
2025-07-18BUY64320.530325.620 325.111USD 20,807 -
2025-07-17BUY48324.690329.870 329.352USD 15,809 -
2025-07-11BUY64314.940321.120 320.502USD 20,512 -
2025-07-10BUY72322.640324.820 324.602USD 23,371 -
2025-07-09BUY72320.870322.680 322.499USD 23,220 -
2025-07-07SELL-48324.130328.240 327.829USD -15,736 -
2025-07-02SELL-200329.770330.000 329.977USD -65,995 -
2025-06-27BUY24322.830323.200 323.163USD 7,756 -
2025-06-26BUY24318.250325.000 324.325USD 7,784 -
2025-06-24SELL-112325.000326.030 325.927USD -36,504 -
2025-06-18BUY64312.320317.540 317.018USD 20,289 -
2025-06-17BUY24308.710309.060 309.025USD 7,417 -
2025-06-16SELL-32308.780309.630 309.545USD -9,905 -
2025-06-13BUY72307.990308.020 308.017USD 22,177 -
2025-06-12SELL-40304.670307.480 307.199USD -12,288 -
2025-06-11BUY88298.580303.850 303.323USD 26,692 -
2025-06-06BUY24300.830310.220 309.281USD 7,423 -
2025-06-05BUY112308.000308.530 308.477USD 34,549 -
2025-06-04BUY16305.310308.930 308.568USD 4,937 -
2025-06-03SELL-8303.770307.850 307.442USD -2,460 -
2025-05-30SELL-976304.560306.000 305.856USD -298,515 -
2025-05-29BUY24292.900293.220 293.188USD 7,037 -
2025-05-27BUY136290.100295.440 294.906USD 40,107 -
2025-05-23BUY120289.960291.220 291.094USD 34,931 -
2025-05-22BUY56289.000291.540 291.286USD 16,312 -
2025-05-19BUY48291.860296.800 296.306USD 14,223 -
2025-05-16BUY24285.310289.750 289.306USD 6,943 -
2025-05-15SELL-16283.400285.000 284.840USD -4,557 -
2025-05-14BUY8267.550270.000 269.755USD 2,158 -
2025-05-13BUY16266.860268.070 267.949USD 4,287 -
2025-05-12BUY56270.190270.200 270.199USD 15,131 -
2025-05-09SELL-40251.150260.000 259.115USD -10,365 -
2025-05-08BUY16258.350270.000 268.835USD 4,301 -
2025-05-07BUY24276.550277.850 277.720USD 6,665 -
2025-05-02BUY888259.390265.000 264.439USD 234,822 -
2025-04-30BUY280263.240263.680 263.636USD 73,818 -
2025-04-29BUY72257.190260.540 260.205USD 18,735 -
2025-04-28BUY56254.850256.570 256.398USD 14,358 -
2025-04-25BUY144251.560253.250 253.081USD 36,444 -
2025-04-24SELL-168242.610243.690 243.582USD -40,922 -
2025-04-23BUY152241.970248.590 247.928USD 37,685 -
2025-04-22BUY64236.750238.630 238.442USD 15,260 -
2025-04-17BUY88234.560235.120 235.064USD 20,686 -
2025-04-15BUY80230.930242.150 241.028USD 19,282 -
2025-04-11BUY128237.770240.000 239.777USD 30,691 -
2025-04-09BUY48243.270245.560 245.331USD 11,776 -
2025-04-08BUY288224.320246.150 243.967USD 70,262 -
2025-04-07BUY96232.950241.830 240.942USD 23,130 -
2025-04-04SELL-128235.740259.160 256.818USD -32,873 -
2025-04-02BUY1,088266.830267.290 267.244USD 290,761 -
2025-04-01BUY8255.760273.610 271.825USD 2,175 -
2025-03-31BUY56270.020271.850 271.667USD 15,213 -
2025-03-28BUY32268.460271.300 271.016USD 8,673 -
2025-03-27BUY16271.020276.570 276.015USD 4,416 -
2025-03-26BUY8269.210281.210 280.010USD 2,240 -
2025-03-25BUY88280.960292.620 291.454USD 25,648 -
2025-03-24BUY104290.700300.900 299.880USD 31,188 -
2025-03-21BUY96283.340289.440 288.830USD 27,728 -
2025-03-19BUY24253.440255.350 255.159USD 6,124 -
2025-03-18BUY288244.300263.300 261.400USD 75,283 -
2025-03-17BUY56253.110253.300 253.281USD 14,184 -
2025-03-14BUY416241.760244.040 243.812USD 101,426 -
2025-03-13BUY80241.750245.140 244.801USD 19,584 -
2025-03-12SELL-400242.430246.370 245.976USD -98,390 -
2025-03-11SELL-296238.740243.450 242.979USD -71,922 -
2025-03-10BUY88233.070244.330 243.204USD 21,402 -
2025-03-07BUY16244.520251.120 250.460USD 4,007 -
2025-03-05BUY120249.230249.820 249.761USD 29,971 -
2025-03-04BUY136242.930244.670 244.496USD 33,251 -
2025-03-03BUY256243.530250.000 249.353USD 63,834 -
2025-02-28BUY208246.750249.340 249.081USD 51,809 -
2025-02-27SELL-40237.100246.380 245.452USD -9,818 -
2025-02-25BUY296245.200251.560 250.924USD 74,274 -
2025-02-21BUY32250.590253.700 253.389USD 8,108 -
2025-02-18SELL-72250.000260.000 259.000USD -18,648 -
2025-02-14SELL-488256.450264.870 264.028USD -128,846 -
2025-02-13BUY8264.890268.520 268.157USD 2,145 -
2025-02-12BUY80265.960268.200 267.976USD 21,438 -
2025-02-07SELL-8276.190278.030 277.846USD -2,223 -
2025-02-06BUY152278.250279.240 279.141USD 42,429 -
2025-02-05BUY40276.310278.440 278.227USD 11,129 -
2025-02-04BUY48271.000277.980 277.282USD 13,310 -
2025-02-03BUY48274.550278.510 278.114USD 13,349 -
2025-01-31BUY88271.310279.340 278.537USD 24,511 -
2025-01-29SELL-8273.990279.700 279.129USD -2,233 -
2025-01-28SELL-72279.190283.560 283.123USD -20,385 -
2025-01-27SELL-128276.730287.220 286.171USD -36,630 -
2025-01-24BUY96278.760279.670 279.579USD 26,840 -
2025-01-23BUY16275.540277.220 277.052USD 4,433 -
2024-12-10BUY400253.910257.990 257.582USD 103,033 -
2024-12-09BUY48255.890258.120 257.897USD 12,379 -
2024-12-06SELL-120256.260257.810 257.655USD -30,919 -
2024-12-05SELL-8251.810255.290 254.942USD -2,040 -
2024-12-03BUY40251.840253.210 253.073USD 10,123 -
2024-11-27SELL-48253.740256.020 255.792USD -12,278 -
2024-11-26BUY168253.350253.740 253.701USD 42,622 -
2024-11-26BUY168253.350253.740 253.701USD 42,622 -
2024-11-25BUY1,929250.980255.460 255.012USD 491,918 -
2024-11-25BUY1,929250.980255.460 255.012USD 491,918 -
2024-11-22SELL-14244.890248.900 248.499USD -3,479 -
2024-11-21SELL-40246.800250.710 250.319USD -10,013 -
2024-11-20SELL-16248.790249.100 249.069USD -3,985 -
2024-11-19BUY8234.270235.940 235.773USD 1,886 -
2024-11-18BUY72232.270242.490 241.468USD 17,386 -
2024-11-11BUY24279.820286.580 285.904USD 6,862 -
2024-11-11BUY24279.820286.580 285.904USD 6,862 -
2024-11-07BUY20272.220275.070 274.785USD 5,496 -
2024-11-07BUY20272.220275.070 274.785USD 5,496 -
2024-11-06BUY192273.010278.210 277.690USD 53,316 -
2024-11-06BUY192273.010278.210 277.690USD 53,316 -
2024-11-05BUY40265.290268.890 268.530USD 10,741 -
2024-11-05BUY40265.290268.890 268.530USD 10,741 -
2024-11-04BUY14269.950272.920 272.623USD 3,817 -
2024-11-04BUY14269.950272.920 272.623USD 3,817 -
2024-11-01BUY21273.910274.030 274.018USD 5,754 -
2024-11-01BUY21273.910274.030 274.018USD 5,754 -
2024-10-30SELL-48281.490287.870 287.232USD -13,787 -
2024-10-30SELL-48281.490287.870 287.232USD -13,787 -
2024-10-29SELL-144284.690287.020 286.787USD -41,297 -
2024-10-29SELL-144284.690287.020 286.787USD -41,297 -
2024-10-28SELL-56286.910290.940 290.537USD -16,270 -
2024-10-28SELL-56286.910290.940 290.537USD -16,270 -
2024-10-21SELL-8292.010295.390 295.052USD -2,360 -
2024-10-21SELL-8292.010295.390 295.052USD -2,360 -
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ALNY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19216,7273,259396,24354.7%
2025-09-18172,875397386,43244.7%
2025-09-17246,547167472,29252.2%
2025-09-1688,84660226,33639.3%
2025-09-15148,25813,572435,68934.0%
2025-09-12134,122300244,96854.8%
2025-09-11219,8687,820411,70253.4%
2025-09-10543,3267,595916,89859.3%
2025-09-09705,54033,7311,550,89945.5%
2025-09-08175,158440388,71545.1%
2025-09-05127,116335311,25240.8%
2025-09-04110,9302,555236,56846.9%
2025-09-03182,3868,982562,92132.4%
2025-09-02132,77014,416358,47637.0%
2025-08-2993,2162,181276,59433.7%
2025-08-2860,1821,254226,86526.5%
2025-08-27277,6671,084440,57763.0%
2025-08-26243,404919447,42154.4%
2025-08-25156,55115,662374,27641.8%
2025-08-22228,5961,309408,15256.0%
2025-08-21123,9962,862248,30049.9%
2025-08-20149,63813,723316,98347.2%
2025-08-19144,3201,143308,39946.8%
2025-08-18371,31834,264525,78670.6%
2025-08-15104,01813,245265,62039.2%
2025-08-14133,2724,443505,52826.4%
2025-08-13183,2711,3901,017,62318.0%
2025-08-12173,0454,046693,01825.0%
2025-08-11239,1997,600451,24853.0%
2025-08-08168,7553,199466,74436.2%
2025-08-07308,8104,452527,39958.6%
2025-08-06202,15112,590548,34936.9%
2025-08-05256,29513,237826,28331.0%
2025-08-04411,11436,303729,94956.3%
2025-08-01350,06060,108764,94345.8%
2025-07-31829,1916,0231,541,01553.8%
2025-07-30533,88514,703942,78856.6%
2025-07-29164,26855384,53742.7%
2025-07-28150,24069571,96526.3%
2025-07-2590,782429298,80130.4%
2025-07-24132,00111,546286,15546.1%
2025-07-23184,14963312,34059.0%
2025-07-22134,7617,553524,61225.7%
2025-07-21113,303101243,11946.6%
2025-07-1884,1179196,31742.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy